P3 Health Partners (PIII) Cost of Revenue (2021 - 2026)

P3 Health Partners (PIII) has 5 years of Cost of Revenue data on file, last reported at $426.1 million in Q4 2025.

• Quarterly Cost of Revenue rose 3.86% year-over-year to $426.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 billion (down 2.57% YoY) and the FY2025 annual result came in at $1.5 billion, down 2.57% from the prior year.
• Cost of Revenue rose to $426.1 million in Q4 2025, from $369.8 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $426.1 million in Q4 2025 to a low of $146.6 million in Q1 2021.
• A 5-year average of $303.7 million and a median of $293.9 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 81.29% — and 2025, when it decreased 7.99%.
• Tracing PIII's Cost of Revenue over 5 years: stood at $244.8 million in 2021, then rose by 9.96% to $269.2 million in 2022, then soared by 36.59% to $367.7 million in 2023, then advanced by 11.57% to $410.2 million in 2024, then grew by 3.86% to $426.1 million in 2025.
• The last three Cost of Revenue figures came in at $426.1 million (Q4 2025), $369.8 million (Q3 2025), and $351.3 million (Q2 2025), per Business Quant data.